Annual FCF
-$63.56 M
+$41.54 M+39.53%
December 31, 2023
Summary
- As of February 8, 2025, BCYC annual free cash flow is -$63.56 million, with the most recent change of +$41.54 million (+39.53%) on December 31, 2023.
- During the last 3 years, BCYC annual FCF has fallen by -$44.57 million (-234.70%).
- BCYC annual FCF is now -2414.12% below its all-time high of -$2.53 million, reached on December 31, 2017.
Performance
BCYC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$40.27 M
+$4.78 M+10.61%
September 30, 2024
Summary
- As of February 8, 2025, BCYC quarterly free cash flow is -$40.27 million, with the most recent change of +$4.78 million (+10.61%) on September 30, 2024.
- Over the past year, BCYC quarterly FCF has increased by +$4.78 million (+10.61%).
- BCYC quarterly FCF is now -219.07% below its all-time high of $33.82 million, reached on June 30, 2023.
Performance
BCYC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$203.53 M
-$38.74 M-23.51%
September 30, 2024
Summary
- As of February 8, 2025, BCYC TTM free cash flow is -$203.53 million, with the most recent change of -$38.74 million (-23.51%) on September 30, 2024.
- Over the past year, BCYC TTM FCF has dropped by -$38.74 million (-23.51%).
- BCYC TTM FCF is now -5390.53% below its all-time high of -$3.71 million, reached on March 31, 2020.
Performance
BCYC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BCYC Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.5% | +10.6% | -23.5% |
| 3 y3 years | -234.7% | +10.6% | -23.5% |
| 5 y5 years | -133.1% | +10.6% | -23.5% |
BCYC Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -277.8% | +39.5% | -219.1% | +43.2% | -1109.8% | at low |
| 5 y | 5-year | -277.8% | +39.5% | -219.1% | +43.2% | -5390.5% | at low |
| alltime | all time | -2414.1% | +39.5% | -219.1% | +43.2% | -5390.5% | at low |
Bicycle Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$40.27 M(-10.6%) | -$203.53 M(+23.5%) |
| Jun 2024 | - | -$45.05 M(-36.4%) | -$164.79 M(+91.8%) |
| Mar 2024 | - | -$70.88 M(+49.7%) | -$85.93 M(+35.2%) |
| Dec 2023 | -$63.56 M(-39.5%) | -$47.34 M(+3000.1%) | -$63.56 M(+32.5%) |
| Sep 2023 | - | -$1.53 M(-104.5%) | -$47.98 M(-13.3%) |
| Jun 2023 | - | $33.82 M(-169.7%) | -$55.30 M(-54.8%) |
| Mar 2023 | - | -$48.51 M(+52.8%) | -$122.45 M(+16.5%) |
| Dec 2022 | -$105.10 M(+524.7%) | -$31.76 M(+258.6%) | -$105.10 M(+23.9%) |
| Sep 2022 | - | -$8.86 M(-73.4%) | -$84.84 M(+55.8%) |
| Jun 2022 | - | -$33.33 M(+7.0%) | -$54.44 M(+61.8%) |
| Mar 2022 | - | -$31.16 M(+170.9%) | -$33.65 M(+100.0%) |
| Dec 2021 | -$16.82 M | -$11.50 M(-153.4%) | -$16.82 M(-25.0%) |
| Sep 2021 | - | $21.55 M(-271.8%) | -$22.42 M(-58.5%) |
| Jun 2021 | - | -$12.54 M(-12.5%) | -$54.05 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$14.33 M(-16.2%) | -$54.16 M(+185.2%) |
| Dec 2020 | -$18.99 M(-37.1%) | -$17.10 M(+69.7%) | -$18.99 M(+163.8%) |
| Sep 2020 | - | -$10.08 M(-20.3%) | -$7.20 M(-13.1%) |
| Jun 2020 | - | -$12.65 M(-160.7%) | -$8.29 M(+123.5%) |
| Mar 2020 | - | $20.84 M(-492.5%) | -$3.71 M(-87.7%) |
| Dec 2019 | -$30.17 M(+10.7%) | -$5.31 M(-52.5%) | -$30.17 M(-11.6%) |
| Sep 2019 | - | -$11.17 M(+38.4%) | -$34.12 M(+23.0%) |
| Jun 2019 | - | -$8.07 M(+43.6%) | -$27.74 M(+9.4%) |
| Mar 2019 | - | -$5.62 M(-39.3%) | -$25.35 M(-7.0%) |
| Dec 2018 | -$27.26 M(+978.5%) | -$9.26 M(+93.6%) | -$27.26 M(+51.5%) |
| Sep 2018 | - | -$4.78 M(-15.8%) | -$18.00 M(+36.2%) |
| Jun 2018 | - | -$5.68 M(-24.7%) | -$13.22 M(+75.3%) |
| Mar 2018 | - | -$7.54 M | -$7.54 M |
| Dec 2017 | -$2.53 M | - | - |
FAQ
- What is Bicycle Therapeutics annual free cash flow?
- What is the all time high annual FCF for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual FCF year-on-year change?
- What is Bicycle Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly FCF year-on-year change?
- What is Bicycle Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Bicycle Therapeutics?
- What is Bicycle Therapeutics TTM FCF year-on-year change?
What is Bicycle Therapeutics annual free cash flow?
The current annual FCF of BCYC is -$63.56 M
What is the all time high annual FCF for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual free cash flow is -$2.53 M
What is Bicycle Therapeutics annual FCF year-on-year change?
Over the past year, BCYC annual free cash flow has changed by +$41.54 M (+39.53%)
What is Bicycle Therapeutics quarterly free cash flow?
The current quarterly FCF of BCYC is -$40.27 M
What is the all time high quarterly FCF for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly free cash flow is $33.82 M
What is Bicycle Therapeutics quarterly FCF year-on-year change?
Over the past year, BCYC quarterly free cash flow has changed by +$4.78 M (+10.61%)
What is Bicycle Therapeutics TTM free cash flow?
The current TTM FCF of BCYC is -$203.53 M
What is the all time high TTM FCF for Bicycle Therapeutics?
Bicycle Therapeutics all-time high TTM free cash flow is -$3.71 M
What is Bicycle Therapeutics TTM FCF year-on-year change?
Over the past year, BCYC TTM free cash flow has changed by -$38.74 M (-23.51%)